What does IntellaRx do?

• Supplies clinical context — diagnosis, treatment plan, prior therapy, comorbidity and metabolic profile — to the clinicians and pharmacists making decisions.
• Confirms that a controlled medication reached the person it was prescribed for, and that a specimen came from the person the result will be attached to.
• Delivers medication in partnership with licensed pharmacies to patients who cannot reliably collect it themselves.
• Screens for behavioral health comorbidity with validated instruments and returns critical findings to clinicians.
• Assesses social circumstances with the patient, and refers where there is a need.
• Detects changes in a local drug supply at population level and produces warnings.
• Maintains an aggregate, current picture of overdose events for an agency’s jurisdiction.
• Reports program outcomes, including bad ones.

Does 42 CFR Part 2 still apply if HIPAA does not?

Agencies sometimes assume that if one confidentiality regime does not apply to them, none does. That is not a safe assumption, and it is worth naming because substance use disorder information is governed by a separate federal regime — 42 U.S.C. § 290dd-2 and 42 C.F.R. Part 2 — with its own scope and its own requirements, which in several respects are stricter than HIPAA’s.

We are not telling you whether it applies to you. We are telling you not to conclude that it does not because something else does not. That is a question for your counsel, and it is one worth asking early rather than after a data flow is built.

How much does IntellaRx cost?

IntellaRx does not publish prices. Scope varies enormously with population size, which components are deployed, and what systems an agency already has, so a published figure would be misleading rather than helpful. Cost is discussed in scoping, in writing, against a defined scope.

Questions this raises

Will you tell us whether HIPAA applies to our program?

No. That is a legal determination about your organization, it varies with the agency, the population and the arrangement, and it is not ours to make. We will describe exactly what data the program touches, where it comes from, who can see it and how long it is held, so that your counsel can make the determination. Be cautious of any vendor who answers this question for you. See questions worth asking a vendor.

Can the program be used to support enforcement activity?

No, and we decline deployments structured that way. Every clinical component depends on patients answering honestly, and a program believed to feed enforcement stops receiving honest answers almost immediately. That is not only an ethical objection; it is why such a deployment would not work. See why trust is load-bearing.

Is IntellaRx a clinic or a pharmacy?

No. IntellaRx does not prescribe, dispense, diagnose or treat. It supplies clinical context to the clinicians and pharmacists making decisions, confirms that medication and specimens belong to the right person, and delivers medication in partnership with licensed pharmacies to patients who cannot reliably collect it themselves.

Do patients have to join the program to get treatment?

No. IntellaRx does not make treatment conditional on participation. A patient who declines any component, including biometric enrollment, a site visit or monitoring, is not removed from care. Behavioral health screening results go back to clinicians, and social needs are assessed with the patient, who is referred where there is a need.

What data does an agency receive from IntellaRx?

Aggregate outcomes. IntellaRx does not report individual behavioral health, social or monitoring data to an agency, and it does not score patients by suspicion. It reports program outcomes, including bad ones, and keeps an aggregate, current picture of overdose events for the agency’s jurisdiction.